2 results
Approved WMORecruiting
The primary objective of the SPIRIT*HF study is to compare Spironolactone to Placebo in reducing the rate…
Approved WMORecruiting
Primary objective: To evaluate the efficacy of inebilizumab in reducing the risk of a disease flare in patients with IgG4-RD.Secondary objectives:• To evaluate the safety and tolerability of inebilizumab in patients with IgG4-RD.• To evaluate the…